ELITE PHARMACEUTICALS INC /NV/ Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Elite Pharmaceuticals Inc /Nv/ Return On Equity for the quarter ending September 30, 2024 was -12.2 %, a 123% decline year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ annual Return On Equity for 2023 was 71.9 %, a 340% increase from 2022.
  • Elite Pharmaceuticals Inc /Nv/ annual Return On Equity for 2022 was 16.3 %, a 72.8% decline from 2021.
  • Elite Pharmaceuticals Inc /Nv/ annual Return On Equity for 2021 was 60.1 %, a 56.2% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 71.9 +55.6 +340% Apr 1, 2023 Mar 31, 2024
2022 16.3 -43.8 -72.8% Apr 1, 2022 Mar 31, 2023
2021 60.1 -77.2 -56.2% Apr 1, 2021 Mar 31, 2022
2020 137 +567 Apr 1, 2020 Mar 31, 2021
2019 -430 -249 -138% Apr 1, 2019 Mar 31, 2020
2018 -181 -147 -433% Apr 1, 2018 Mar 31, 2019
2017 -33.9 -23 -209% Apr 1, 2017 Mar 31, 2018
2016 -11 -12.3 -924% Apr 1, 2016 Mar 31, 2017
2015 1.33 +22.6 Apr 1, 2015 Mar 31, 2016
2014 -21.2 -271 -109% Apr 1, 2014 Mar 31, 2015
2013 249 +256 Apr 1, 2013 Mar 31, 2014
2012 -6.48 Apr 1, 2012 Mar 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.